90190 Federal Register / Vol. 88, No. 249 / Friday, December 29, 2023 / Notices 

• Andrea Haynes, MD, Attending 

Physician, PPC Austin Family Health 

Center . 

• Lydia Isaac, Vice President for 

Health Equity and Policy, National 

Urban League. 

• Vacheria Keys, Director of Policy 

and Regulatory Affairs, National 

Association of Community Health 

Centers 

• Daisy Kim, Principal Legislative 

Analyst, University of California 

System. 

• Lynn Kimball, Executive Director, 

Aging and Long-Term Care of Eastern 

Washington. 

• Erin Loubier, Senior Director for 

Health and Legal Integration and 

Payment Innovation, Whitman-Walker 

Health. 

• Dr. Alister Martin, CEO, A Healthier 

Democracy; Physician, Massachusetts 

General Hospital; Assistant Professor, 

Harvard Medical School. 

• Neil Meltzer, President and CEO, 

LifeBridge Health. 

• Dr. Carol Podgorski, Professor of 

Psychiatry, Associate Chair of Academic 

Affairs, University of Rochester Medical 

Center. 

• Melanie Prince, President/CEO 

MAPYourWay, LLC; Immediate Past 

President, Case Management Society of 

America. 

• Jina Ragland, Associate State 

Director of Advocacy and Outreach, 

AARP Nebraska. 

• Carrie Rogers, Associate Director, 

Community Catalyst. 

• Tricia Sandiego, Senior Advisor, 

Caregiving and Health Team, AARP. 

• Marsha Schofield, President, 

Marsha Schofield & Associates LLC. 

• Mina Schultz, Health Policy and 

Advocacy Manager, Young Invincibles. 

• Matthew Snider, JD, Senior Policy 

Analyst, Unidos US. 

• Daniel Spirn, Vice President, 

Government Relations, Utilization 

Review Accreditation Commission. 

• Emily Whicheloe, Director of 

Education, Medicare Rights Center. 

II. Meeting Format and Agenda 

In accordance with section 10(a) of 

the FACA, this notice announces a 

meeting of the APOE. The agenda for 

the February 1, 2024 meeting will 

include the following: 

• Welcome and opening remarks from 

CMS leadership. 

• Recap of the previous (September 

21, 2023) meeting. 

• Presentations on CMS programs, 

initiatives, and priorities; discussion of 

panel recommendations. 

• An opportunity for public 

comment. 

• Meeting adjourned. 

Individuals or organizations that wish 

to make a 5-minute oral presentation on 

an agenda topic should submit a written 

copy of the oral presentation to the DFO 

at the address listed in the ADDRESSES

section of this notice by the date listed 

in the DATES section of this notice. The 

number of oral presentations may be 

limited by the time available. 

Individuals not wishing to make an oral 

presentation may submit written 

comments to the DFO at the address 

listed in the ADDRESSES section of this 

notice by the date listed in the DATES

section of this notice. 

III. Meeting Participation 

The meeting is open to the public, but 

attendance is limited to registered 

participants. Persons wishing to attend 

this meeting must register at the 

following weblink https://CMS-APOEFeb2024.rsvpify.com or by contacting 

the DFO at the address or telephone 

number listed in the FOR FURTHER

INFORMATION CONTACT section of this 

notice by the date specified in the DATES

section of this notice. This meeting will 

be held virtually. Individuals who are 

not registered in advance will be unable 

to attend this meeting. 

IV. Collection of Information 

This document does not impose 

information collection requirements, 

that is, reporting, recordkeeping, or 

third-party disclosure requirements. 

Consequently, there is no need for 

review by the Office of Management and 

Budget under the authority of the 

Paperwork Reduction Act of 1995 (44 

U.S.C. chapter 35). 

The Administrator of the Centers for 

Medicare & Medicaid Services (CMS), 

Chiquita Brooks-LaSure, having 

reviewed and approved this document, 

authorizes Chyana Woodyard, who is 

the Federal Register Liaison, to 

electronically sign this document for 

purposes of publication in the Federal 

Register. 

Chyana Woodyard, 

Federal Register Liaison, Centers for Medicare 

& Medicaid Services. 

[FR Doc. 2023–28791 Filed 12–28–23; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Proposed Collection: Public 

Comment Request; Information 

Collection Request Title: National 

Health Service Corps Scholar/Students 

to Service Travel Worksheet, OMB No. 

0915–0278—Revision 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement for opportunity for public 

comment on proposed data collection 

projects of the Paperwork Reduction Act 

of 1995, HRSA announces plans to 

submit an Information Collection 

Request (ICR), described below, to the 

Office of Management and Budget 

(OMB). Prior to submitting the ICR to 

OMB, HRSA seeks comments from the 

public regarding the burden estimate, 

below, or any other aspect of the ICR. 

DATES: Comments on this ICR should be 

received no later than February 27, 

2024. 

ADDRESSES: Submit your comments to 

paperwork@hrsa.gov or mail the HRSA 

Information Collection Clearance 

Officer, Room 14N39, 5600 Fishers 

Lane, Rockville, Maryland 20857. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and draft 

instruments, email paperwork@hrsa.gov 

or call Joella Roland, the HRSA 

Information Collection Clearance 

Officer, at (301) 443–3983. 

SUPPLEMENTARY INFORMATION: When 

submitting comments or requesting 

information, please include the ICR title 

for reference. 

Information Collection Request Title: 

National Health Service Corps Scholar/ 

Students to Service Travel Worksheet, 

OMB No. 0915–0278—Revision. 

Abstract: Clinicians participating in 

the HRSA National Health Service 

Corps (NHSC) Scholarship Program and 

the Students to Service (S2S) Loan 

Repayment Program use the online 

Travel Request Worksheet to request 

and receive travel funds from the federal 

government to visit eligible NHSC sites 

to which they may be assigned in 

accordance with the Public Health 

Service Act, section 331(c)(1). 

The travel approval process is 

initiated when an NHSC scholar or S2S 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 249 / Friday, December 29, 2023 / Notices 90191 

participant notifies the NHSC of an 

impending interview at one or more 

NHSC-approved practice sites. The 

Travel Request Worksheet is also used 

to initiate the relocation process after an 

NHSC scholar or S2S participant has 

successfully been matched to an 

approved practice site in accordance 

with the Public Health Service Act, 

section 331(c)(3). Upon receipt of a 

completed Travel Request Worksheet, 

the NHSC will review and approve or 

disapprove the request and promptly 

notify the NHSC scholar or S2S 

participant and the NHSC logistics 

contractor regarding travel arrangements 

and authorization of the funding for the 

site visit or relocation. 

Need and Proposed Use of the 

Information: This information will 

facilitate NHSC scholar and S2S 

participants’ receipt of federal travel 

funds that are used to visit high-need 

NHSC-approved practice sites. The 

Travel Request Worksheet is also used 

to initiate the relocation process after a 

NHSC scholar or S2S participant has 

successfully been matched to an 

approved practice site. 

Likely Respondents: Clinicians 

participating in the NHSC Scholarship 

Program and the S2S Loan Repayment 

Program. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose, or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating, and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Travel Request Worksheet .................................................. 800 2 1,600 .0667 106.72 

Total .............................................................................. 800 ........................ 1,600 ........................ 106.72 

HRSA specifically requests comments 

on: (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions; (2) the accuracy of the 

estimated burden; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2023–28768 Filed 12–28–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Topics in Anti-Infective 

Therapeutics. 

Date: January 10, 2024. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Marcus Ferrone, PHARMD 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 402–2371, marcus.ferrone@

nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: December 22, 2023. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2023–28722 Filed 12–28–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Stimulants and HIV: Addressing 

Contemporary and Recurring Epidemics. 

Date: February 14, 2024. 

Time: 12:00 p.m. to 1:45 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Marisa Srivareerat, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Office of Extramural Policy, National 

Institute on Drug Abuse, NIH, 301 North 


ddrumheller on DSK120RN23PROD with NOTICES1